The Mac
@TheMac
13 June, 06:37
In these past 3 years, since that article was published, two intravenously administered nanoparticles have been FDA and EMA approved,
Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
The Mac
@TheMac
13 June, 06:39
In response The Mac to his Publication
Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
Cooke obtained a pharmacy degree at Trinity College, Dublin, Ireland in 1982, following which she remained at Trinity to complete Masters degrees in Science and in Business Administration [3]
Starting in 1985, she held various positions in the pharmaceutical industry and from 1991 to 1998 she was a board member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), a lobbying organisation of the largest European pharmaceutical companies.[4][5] There she spent eight years lobbying for the "Big 30" of the European pharmaceutical industry, including Pfizer, AstraZeneca, Novartis, and Johnson & Johnson.[6]
Starting in 1985, she held various positions in the pharmaceutical industry and from 1991 to 1998 she was a board member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), a lobbying organisation of the largest European pharmaceutical companies.[4][5] There she spent eight years lobbying for the "Big 30" of the European pharmaceutical industry, including Pfizer, AstraZeneca, Novartis, and Johnson & Johnson.[6]
06:43 AM - Jun 13, 2021
In response The Mac to his Publication
Only people mentioned by TheMac in this post can reply
The Mac
@TheMac
13 June, 06:44
In response The Mac to his Publication
She was appointed as Head of Regulation of Medicines and other Health Technologies with the World Health Organization (WHO) in 2016,.[3] In November 2020 she was appointed Executive Director of the EMA,[1] also taking the position of chairperson at the International Coalition of Medicines Regulatory Authorities (ICMRA) at the same time.[2]
On 16 March 2021, Cooke led an EMA press conference to inform about the ongoing investigation into reports of side-effects related to the Oxford–AstraZeneca COVID-19 vaccine. Cooke said the EMA remains "firmly convinced" that the vaccine benefits outweigh the risks of potential side effects.
On 16 March 2021, Cooke led an EMA press conference to inform about the ongoing investigation into reports of side-effects related to the Oxford–AstraZeneca COVID-19 vaccine. Cooke said the EMA remains "firmly convinced" that the vaccine benefits outweigh the risks of potential side effects.
Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
The Mac
@TheMac
13 June, 06:47
In response The Mac to his Publication
Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396